ICU Medical Q3 2022 revenue $597.9M; GAAP loss $(0.55)/share; adj EPS $1.75

ICU MEDICAL INC/DE

2022-Q3 EPS reported -$2.47 revenue$1,701,983,000

Revenue $597.9M vs $336.1M YoY (+78%); GAAP net loss $(13.2)M ($(0.55)/diluted share).
Adjusted diluted EPS $1.75 vs $2.07 YoY; adjusted EBITDA $92.6M vs $71.9M.
GAAP gross margin 31% vs 38% YoY; gross profit $186.4M vs $127.8M.
Reaffirmed fiscal year 2022 guidance; no specific guidance numbers provided.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

ICU MEDICAL INC/DE reported For the quarter ended September 30, 2022 results: revenue Third quarter 2022 revenue was $597.9 million, net income GAAP net loss for the third quarter of 2022 was $(13.2) million, EPS Adjusted diluted earnings per share for the third quarter of 2022 was $1.75. Guidance reaffirmed.

Period: For the quarter ended September 30, 2022
Revenue: Third quarter 2022 revenue was $597.9 million
Net income: GAAP net loss for the third quarter of 2022 was $(13.2) million
EPS: Adjusted diluted earnings per share for the third quarter of 2022 was $1.75
Guidance: reaffirmed
Result: reported results

Exact text from the filing

ICU Medical Announces Third Quarter 2022 Results The Company Reaffirms 2022 Fiscal Year Guidance

View on SEC.gov

20 earnings releases filed in the last 30 days. Browse all earnings releases →

ICU MEDICAL INC/DE filing history →

Source: SEC EDGAR

accession 0000883984-22-000044

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.